Middle East And Africa Gene Synthesis Market
시장 규모 (USD 10억)
연평균 성장률 :
% 
 예측 기간 |
2022 –2029 |
 시장 규모(기준 연도) |
USD 45.53 Million |
 시장 규모(예측 연도) |
USD 166.43 Million |
 연평균 성장률 |
% |
| 주요 시장 플레이어 |
>중동 및 아프리카 유전자 합성 시장, 구성 요소(합성기, 소모품, 소프트웨어 및 서비스), 유전자 유형(표준 유전자, 익스프레스 유전자, 복합 유전자 및 기타), 유전자 합성 유형(유전자 라이브러리 합성 및 맞춤형 유전자 합성), 응용 분야(합성 생물학, 유전 공학, 백신 설계, 치료 항체 및 기타), 방법(고체상 합성, 칩 기반 DNA 합성 및 PCR 기반 효소 합성), 최종 사용자(학술 및 연구 기관, 진단 실험실, 바이오 기술 및 제약 회사 및 기타), 유통 채널(직접 입찰, 온라인 유통 및 제3자 유통업체), 산업 동향 및 2029년까지의 예측.
중동 및 아프리카 유전자 합성 시장 분석 및 통찰력
유전자 합성은 합성 생물학을 사용하여 실험실에서 인공 유전자를 만드는 과정입니다. 재조합 단백질의 생성은 유전자 합성이 핵심 도구로 부상하고 있는 재조합 DNA 기술의 수많은 응용 분야 중 하나입니다. 전통적인 클로닝 및 돌연변이 방법은 새로운 유전자 합성으로 빠르게 대체되고 있으며, 이를 통해 템플릿이 없는 핵산도 생산할 수 있습니다.
중동 및 아프리카 유전자 합성 시장은 2022년부터 2029년까지의 예측 기간 동안 시장 성장을 이룰 것으로 예상됩니다. Data Bridge Market Research는 시장이 2022년부터 2029년까지의 예측 기간 동안 17.4%의 CAGR로 성장하고 있으며 2021년의 4,553만 달러에서 2029년까지 1억 6,643만 달러에 도달할 것으로 분석합니다.
|
보고서 메트릭 |
세부 |
|
예측 기간 |
2022년부터 2029년까지 |
|
기준 연도 |
2021 |
|
역사적 연도 |
2020 (2019-2014까지 사용자 정의 가능) |
|
양적 단위 |
수익 (단위: USD 백만) |
|
다루는 세그먼트 |
구성 요소별(합성기, 소모품, 소프트웨어 및 서비스), 유전자 유형(표준 유전자, 익스프레스 유전자, 복합 유전자 및 기타), 유전자 합성 유형(유전자 라이브러리 합성 및 사용자 정의 유전자 합성), 응용 프로그램(합성 생물학, 유전자 공학, 백신 설계, 치료 항체 및 기타), 방법(고체상 합성, 칩 기반 DNA 합성 및 PCR 기반 효소 합성), 최종 사용자(학술 및 연구 기관, 진단 연구소, 바이오텍 및 제약 회사 및 기타), 유통 채널(직접 입찰, 온라인 유통 및 제3자 유통업체) |
|
적용 국가 |
남아프리카공화국, 사우디아라비아, UAE, 이집트, 이스라엘, 기타 중동 국가, 아프리카. |
|
시장 참여자 포함 |
Genescript, Synbio Technologies, Proteogenix, Bio Basic Inc., ATG: biosynthetic GmbH, Merck KGaA, Ginkgo Bioworks, Evonetix, ProMab Biotechnologies, Inc., CSBio, Azenta US, Inc. 등이 있습니다. |
시장 정의
Gene synthesis refers to the chemical synthesis of DNA strand base-by base. Unlike DNA replication that occurs in cells or by Polymerase Chain Reaction (PCR), gene synthesis does not require a template strand. Rather, gene synthesis involves the step-wise addition of nucleotides to a single-stranded molecule, which then serves as a template for the creation of a complementary strand. Gene synthesis is the fundamental technology upon which the field of synthetic biology has been built.
Gene Synthesis Market Dynamics
This section deals with understanding the market drivers, opportunities, restraints, and challenges. All of this is discussed in detail as below:
Drivers
- INCREASED PREVALENCE OF CHRONIC INFECTIOUS DISEASES
Bacterial and viral diseases are rapidly expanding due to the rising prevalence of infectious diseases worldwide. As a result, the demand for novel and effective therapies has increased to fight against such deadly diseases. These diseases can be cured by using chemical drugs and biological therapies, including gene therapy. By applying genomics, the management of infectious and endemic diseases has been enhanced. It also allows us to understand emerging drug resistance and identify targets for new therapeutics and vaccines. For the treatment of infectious diseases, gene therapy has attracted many researchers as it can be treated by using recombinant DNA technology, DNA &RNA ribozyme, and single chain antibodies.
As the rising prevalence of the chronic infectious disease is increasing globally, the demand for vaccines and effective gene therapy has also risen, which has increased the demand for novel genes with a significant application for research activities and drug and vaccine manufacturing. Thus, the rising prevalence of infectious diseases is acting as the driver for the gene synthesis market growth.
- RISING ADOPTION OF GENE THERAPY
Gene therapy is an advanced technique that includes the usage of several genes for the prevention of a particular disease type. The technique involves the insertion of genes into patient cells instead of drugs and surgery. Due to increased demand for novel and long-lasting therapy results, the adoption of gene therapy is rising. Gene therapies demand synthetic gene constructs, among other gene products, to accelerate gene therapy development. Due to the rise in genetic diseases, the demand for a proper cure is one major factor, and with the help of gene therapy, a particular disease type can be cured.
Due to the increased demand, leaders are constantly focused on producing gene therapy products, achieving approval, and marketing authorizations.
Lifesaving medicines and therapies are in huge demand to provide quality life to different kinds of patients. These rising numbers of patients are largely dependent upon the gene therapies available to achieve a proper cure. To manufacture gene therapies, synthetic and novel genes are required, which can be achieved by the gene synthesis technique. Thus, the rising adoption of gene therapy is expected to act as a driver for the gene synthesis market.
- EXPANSION OF SYNTHETIC BIOLOGY
The incorporation of engineering principles into biology is termed synthetic biology. DNA genome can be reassembled with the help of synthetic biology as it involves the chemical synthesis of DNA by combining it with its genome. Oligonucleotides can be constructed in a short period by incorporating the usage of gene synthesis services, software, and consumables. As synthetic biology products' demand increases worldwide, gene synthesis products and services are also increasing.
Thus, due to its effective and innovative products, the demand for synthetic biology products is increasing globally, which is expected to act as a driving factor for the gene synthesis market.
Opportunities
-
RISING HEALTHCARE EXPENDITURE
Healthcare expenditure has increased worldwide as people's disposable income in various countries is increasing. Moreover, to accomplish the population requirements, government bodies and healthcare organizations are taking the initiative by virtue of accelerating healthcare expenditure.
Also, the strategic initiatives taken by key market players will provide structural integrity and future opportunities for the medical device testing market in the forecast period of 2022-2029.
Restraints/Challenges
HIGH COST OF THE GENE SYNTHESIS PROCESS
However, the barriers to the gene synthesis techniques and the high cost of the gene synthesis process in some regions may impede the less growth of the gene synthesis procedures hampering the growth of the market. Additionally, high competition in medical technology industries and long lead time for the overseas qualification can be challenging factors for the growth of the market
This gene synthesis market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, the impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the gene synthesis market, contact Data Bridge Market Research for an Analyst Brief. Our team will help you to make an informed market decision to achieve market growth.
Recent Development
- In December 2020, Twist Bioscience launched clonal-ready gene fragments to complete the offering of genes. The fragments launched can be used with adapters or without adapters to build up the perfect clones. The clonal-ready gene fragments are compatible with the protein expression pathways, enzyme engineering, and gene expression, among others.
- In 2020, according to an article published in an ACS journal, a total estimated 19.3 million new cancer cases and almost 10.0 million cancer deaths were reported worldwide. This suggests that cancer coverage is suboptimal, and there is a great need to implement high cancer coverage all over the world.
Middle East and Africa Gene Synthesis Market Scope
The Middle East and Africa gene synthesis market are segmented into component, gene type, gene synthesis type, application, method, end user, and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to make strategic decisions to identify core market applications.
Component
- Synthesizers
- Consumables
- Software & services
On the basis of component, the Middle East and Africa gene synthesis market is segmented into synthesizers, consumables, and software & services.
Gene Type
- Standard gene
- Express gene
- Complex gene
- Others
On the basis of gene type, the Middle East and Africa gene synthesis market is segmented into the standard gene, express gene, complex gene and others.
Gene Synthesis Type
- Gene library synthesis
- Custom gene synthesis
On the basis of gene synthesis type, the Middle East and Africa gene synthesis market is segmented into gene library synthesis and custom gene synthesis.
Application
- Synthetic biology,
- Genetic engineering,
- Vaccine design,
- Therapeutics antibodies
- Others
On the basis of application, the Middle East and Africa gene synthesis market is segmented into synthetic biology, genetic engineering, vaccine design, therapeutics antibodies, and others.
Method
- Solid based synthesis,
- Chip-based DNA synthesis
- PCR-based enzyme synthesis
On the basis of the method, the Middle East and Africa gene synthesis market is segmented into solid based synthesis, chip-based DNA synthesis, and PCR-based enzyme synthesis.
End User
- Academic & research institutes,
- Diagnostics laboratories,
- Biotech & pharmaceutical companies
- Others
On the basis of end users, the Middle East and Africa gene synthesis market is segmented into academic & research institutes, diagnostics laboratories, biotech & pharmaceutical companies, and others.
Distribution Channel
- Direct tender
- Online distribution
- Third party distributors
On the basis of distribution channels, the Middle East and Africa gene synthesis market is segmented into direct tender, online distribution, and third party distributors.
Gene Synthesis Market Regional Analysis/Insights
The gene synthesis market is analyzed, and market size insights and trends are provided by the country, component, gene type, gene synthesis type, application, method, end user, and distribution channel, as referenced above.
Saudi Arabia dominates the gene synthesis market in terms of market share and market revenue and will continue to flourish its dominance during the forecast period. This is due to the rising need for the verification and validation of gene synthesis processes in the region, and rapid research development is boosting the market
The country section of the report also provides individual market-impacting factors and changes in regulations in the market that impact the current and future trends of the market. Data points, such as new and replacement sales, country demographics, disease epidemiology, and import-export tariffs, are some of the major pointers used to forecast the market scenario for individual countries. In addition, the presence and availability of global brands and their challenges faced due to high competition from local and domestic brands, and the impact of sales channels are considered while providing forecast analysis of the country data.
Competitive Landscape and Gene Synthesis Market Share Analysis
The gene synthesis market competitive landscape provides details by the competitors. Details include company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, and application dominance. The above data points provided are only related to the companies focus on the gene synthesis market.
Some of the major players operating in the gene synthesis market are ATDBio Ltd (Subsidiary of Biotage), General Biosystems, Inc., MACROGEN CO., LTD., Boster Biological Technology, Creative Biogene, Bioneer Pacific, exonbio, trenzyme GmbH, Twist Bioscience, BioCat GmbH (Subsidiary of AddLife AB), OriGene Technologies, Inc., Integrated DNA Technologies, Inc. 9Subsidiary of Danaher Corporation), Eurofins Scientific, NZYTech, Lda. - Genes and Enzymes, Ansa Biotechnologies, Inc., Thermo Fisher Scientific, Genescript, Synbio Technologies, Proteogenix, Bio Basic Inc., ATG:biosynthetics GmbH, Merck KGaA, Kaneka Eurogentec S.A, Ginkgo Bioworks, Bbi-lifesciences, Evonetix, ProMab Biotechnologies, Inc., GCC Biotech (INDIA) Pvt. Ltd., CSBio, Azenta US, Inc., and among others.
Research Methodology
데이터 수집 및 기준 연도 분석은 대규모 샘플 크기의 데이터 수집 모듈을 사용하여 수행됩니다. 시장 데이터는 시장 통계 및 일관된 모델을 사용하여 분석 및 추정됩니다. 또한 시장 점유율 분석 및 주요 추세 분석은 시장 보고서의 주요 성공 요인입니다. DBMR 연구팀에서 사용하는 주요 연구 방법론은 데이터 마이닝, 시장에 대한 데이터 변수의 영향 분석 및 기본(산업 전문가) 검증을 포함하는 데이터 삼각 측량입니다. 이 외에도 데이터 모델에는 공급업체 포지셔닝 그리드, 시장 타임라인 분석, 시장 개요 및 가이드, 회사 포지셔닝 그리드, 회사 시장 점유율 분석, 측정 표준, 중동 및 아프리카 대 지역 및 공급업체 점유율 분석이 포함됩니다. 추가 문의 사항이 있는 경우 분석가에게 전화를 요청하십시오.
SKU-
세계 최초의 시장 정보 클라우드 보고서에 온라인으로 접속하세요
- 대화형 데이터 분석 대시보드
- 높은 성장 잠재력 기회를 위한 회사 분석 대시보드
- 사용자 정의 및 질의를 위한 리서치 분석가 액세스
- 대화형 대시보드를 통한 경쟁자 분석
- 최신 뉴스, 업데이트 및 추세 분석
- 포괄적인 경쟁자 추적을 위한 벤치마크 분석의 힘 활용
목차
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATION
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHIC SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 RESEARCH METHODOLOGY
2.6 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.7 MULTIVARIATE MODELLING
2.8 COMPONENT SEGMENT LIFELINE CURVE
2.9 DBMR MARKET POSITION GRID
2.1 VENDOR SHARE ANALYSIS
2.11 MARKET APPLICATION COVERAGE GRID
2.12 THE CATEGORY VS TIME GRID
2.13 SECONDARY SOURCES
2.14 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PESTEL
4.2 PORTER'S FIVE FORCES MODEL
5 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET: REGULATIONS
6 MARKET OVERVIEW
6.1 DRIVERS
6.1.1 INCREASED PREVALENCE OF CHRONIC INFECTIOUS DISEASES
6.1.2 RISING ADOPTION OF GENE THERAPY
6.1.3 EXPANSION OF SYNTHETIC BIOLOGY
6.1.4 RISING INTEREST OF GENE SYNTHESIS IN THE FIELD OF MOLECULAR BIOLOGY
6.2 RESTRAINTS
6.2.1 LACK OF TRAINED PROFESSIONALS
6.2.2 ETHICAL ISSUES
6.2.3 LONG APPROVAL PROCESS
6.3 OPPORTUNITIES
6.3.1 RISE IN HEALTHCARE EXPENDITURE
6.3.2 STRATEGIC INITIATIVES BY KEY PLAYERS
6.3.3 RISING DEMAND FOR CUSTOMIZED MEDICATIONS
6.4 CHALLENGES
6.4.1 TECHNICAL LIMITATIONS ACROSS PRODUCTION PROCESS
6.4.2 LACK OF WELL DEFINED PATENT SYSTEM
7 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET, BY COMPONENT
7.1 OVERVIEW
7.2 SOFTWARE & SERVICES
7.3 CONSUMABLES
7.3.1 REAGENTS
7.3.2 ASSAYS
7.3.3 PROBES & DYES
7.3.4 OTHERS
7.4 SYNTHESIZER
7.4.1 COLUMN-BASED SYNTHESIZERS
7.4.2 MICROARRAY-BASED SYNTHESIZERS
8 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET, BY GENE TYPE
8.1 OVERVIEW
8.2 STANDARD GENE
8.3 COMPLEX GENE
8.4 EXPRESS GENE
8.5 OTHERS
9 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE
9.1 OVERVIEW
9.2 CUSTOM GENE SYNTHESIS
9.2.1 STANDARD GENE
9.2.2 COMPLEX GENE
9.2.3 EXPRESS GENE
9.2.4 OTHERS
9.3 GENE LIBRARY SYNTHESIS
9.3.1 STANDARD GENE
9.3.2 COMPLEX GENE
9.3.3 EXPRESS GENE
9.3.4 OTHERS
10 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET, BY APPLICATION
10.1 OVERVIEW
10.2 SYNTHETIC BIOLOGY
10.2.1 CUSTOM GENE SYNTHESIS
10.2.2 GENE LIBRARY SYNTHESIS
10.3 GENETIC ENGINEERING
10.3.1 CUSTOM GENE SYNTHESIS
10.3.2 GENE LIBRARY SYNTHESIS
10.4 THERAPEUTIC ANTIBODIES
10.4.1 CUSTOM GENE SYNTHESIS
10.4.2 GENE LIBRARY SYNTHESIS
10.5 VACCINE DESIGN
10.5.1 CUSTOM GENE SYNTHESIS
10.5.2 GENE LIBRARY SYNTHESIS
10.6 OTHERS
11 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET, BY METHOD
11.1 OVERVIEW
11.2 PCR-BASED ENZYME SYNTHESIS
11.3 CHIP-BASED DNA SYNTHESIS
11.4 SOLID BASED SYNTHESIS
12 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET, BY END USER
12.1 OVERVIEW
12.2 ACADEMIC & RESEARCH INSTITUTE
12.3 BIOTECH & PHARMACEUTICAL COMPANIES
12.4 DIAGNOSTIC LABORATORIES
12.5 OTHERS
13 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET, BY DISTRIBUTION CHANNEL
13.1 OVERVIEW
13.2 DIRECT TENDER
13.3 ONLINE DISTRIBUTION
13.4 THIRD PARTY DISTRIBUTORS
14 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET, BY REGION
14.1 MIDDLE EAST &AFRICA
14.1.1 SAUDI ARABIA
14.1.2 SOUTH AFRICA
14.1.3 U.A.E.
14.1.4 ISRAEL
14.1.5 EGYPT
14.1.6 REST OF MIDDLE EAST & AFRICA
15 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET: COMPANY LANDSCAPE
15.1 COMPANY SHARE ANALYSIS: MIDDLE EAST & AFRICA
16 SWOT ANALYSIS
17 COMPANY PROFILE
17.1 INTEGRATED DNA TECHNOLOGIES, INC. (A SUBSIDIARY OF DANAHER)
17.1.1 COMPANY SNAPSHOT
17.1.2 COMPANY SHARE ANALYSIS
17.1.3 PRODUCT PORTFOLIO
17.1.4 RECENT DEVELOPMENTS
17.2 THERMO FISHER SCIENTIFIC INC.
17.2.1 COMPANY SNAPSHOT
17.2.2 REVENUE ANALYSIS
17.2.3 COMPANY SHARE ANALYSIS
17.2.4 PRODUCT PORTFOLIO
17.2.5 RECENT DEVELOPMENT
17.3 EUROFINS SCIENTIFIC
17.3.1 COMPANY SNAPSHOT
17.3.2 REVENUE ANALYSIS
17.3.3 COMPANY SHARE ANALYSIS
17.3.4 SERVICE PORTFOLIO
17.3.5 RECENT DEVELOPMENT
17.4 MERCK KGAA
17.4.1 COMPANY SNAPSHOT
17.4.2 REVENUE ANALYSIS
17.4.3 COMPANY SHARE ANALYSIS
17.4.4 PRODUCT PORTFOLIO
17.4.5 RECENT DEVELOPMENT
17.5 KANEKA EUROGENTEC S.A.
17.5.1 COMPANY SNAPSHOT
17.5.2 REVENUE ANALYSIS
17.5.3 COMPANY SHARE ANALYSIS
17.5.4 PRODUCT PORTFOLIO
17.5.5 RECENT DEVELOPMENTS
17.6 ANSA BIOTECHNOLOGIES, INC
17.6.1 COMPANY SNAPSHOT
17.6.2 PRODUCT PORTFOLIO
17.6.3 RECENT DEVELOPMENTS
17.7 ATD BIO LTD
17.7.1 COMPANY SNAPSHOT
17.7.2 REVENUE ANALYSIS
17.7.3 PRODUCT PORTFOLIO
17.7.4 RECENT DEVELOPMENTS
17.8 ATG:BIOSYNTHETICS GMBH
17.8.1 COMPANY SNAPSHOT
17.8.2 PRODUCT PORTFOLIO
17.8.3 RECENT DEVELOPMENTS
17.9 AZENTUS US, INC (2021)
17.9.1 COMPANY SNAPSHOT
17.9.2 REVENUE ANALYSIS
17.9.3 PRODUCT PORTFOLIO
17.9.4 RECENT DEVELOPMENT
17.1 BBI LIFESCIENCES CORPORATION
17.10.1 COMPANY SNAPSHOT
17.10.2 PRODUCT PORTFOLIO
17.10.3 RECENT DEVELOPMENTS
17.11 BIO BASIC INC.
17.11.1 COMPANY SNAPSHOT
17.11.2 PRODUCT PORTFOLIO
17.11.3 RECENT DEVELOPMENTS
17.12 BIOCAT GMBH
17.12.1 COMPANY SNAPSHOT
17.12.2 PRODUCT PORTFOLIO
17.12.3 RECENT DEVELOPMENTS
17.13 BIONEER PACIFIC
17.13.1 COMPANY SNAPSHOT
17.13.2 PRODUCT PORTFOLIO
17.13.3 RECENT DEVELOPMENT
17.14 BOSTER BIOLOGICAL TECHNOLOGY
17.14.1 COMPANY SNAPSHOT
17.14.2 SERVICE PORTFOLIO
17.14.3 RECENT DEVELOPMENT
17.15 CSBIO
17.15.1 COMPANY SNAPSHOT
17.15.2 PRODUCT PORTFOLIO
17.15.3 RECENT DEVELOPMENTS
17.16 CREATIVE BIOGENE
17.16.1 COMPANY SNAPSHOT
17.16.2 RODUCTPORTFOLIO
17.16.3 RECENT DEVELOPMENT
17.17 EVONETIX
17.17.1 COMPANY SNAPSHOT
17.17.2 PRODUCT PORTFOLIO
17.17.3 RECENT DEVELOPMENTS
17.18 EXONBIO
17.18.1 COMPANY SNAPSHOT
17.18.2 PRODUCT PORTFOLIO
17.18.3 RECENT DEVELOPMENT
17.19 GCC BIOTECH (INDIA) PVT. LTD.
17.19.1 COMPANY SNAPSHOT
17.19.2 PRODUCT PORTFOLIO
17.19.3 RECENT DEVELOPMENT
17.2 GINKGO BIOWORKS (2021)
17.20.1 COMPANY SNAPSHOT
17.20.2 REVENUE ANALYSIS
17.20.3 PRODUCT PORTFOLIO
17.20.4 RECENT DEVELOPMENTS
17.21 GENERAL BIOSYSTEMS INC
17.21.1 COMPANY SNAPSHOT
17.21.2 PRODUCT PORTFOLIO
17.21.3 RECENT DEVELOPMENTS
17.22 GENSCRIPT
17.22.1 COMPANY SNAPSHOT
17.22.2 REVENUE ANALYSIS
17.22.3 PRODUCT PORTFOLIO
17.22.4 RECENT DEVELOPMENTS
17.23 MACROGEN CO., LTD. (A SUBSIDIARY OF MACROGEN, INC)
17.23.1 COMPANY SNAPSHOT
17.23.2 REVENUE ANALYSIS
17.23.3 PRODUCT PORTFOLIO
17.23.4 RECENT DEVELOPMENTS
17.24 NZYTECH, LDA. - GENES AND ENZYMES.
17.24.1 COMPANY SNAPSHOT
17.24.2 PRODUCT PORTFOLIO
17.24.3 RECENT DEVELOPMENT
17.25 ORIGENE TECHNOLOGIES, INC
17.25.1 COMPANY SNAPSHOT
17.25.2 PRODUCT PORTFOLIO
17.25.3 RECENT DEVELOPMENTS
17.26 PROMAB BIOTECHNOLOGIES
17.26.1 COMPANY SNAPSHOT
17.26.2 PRODUCT PORTFOLIO
17.26.3 RECENT DEVELOPMENTS
17.27 PROTEOGENIX
17.27.1 COMPANY SNAPSHOT
17.27.2 PRODUCT PORTFOLIO
17.27.3 RECENT DEVELOPMENTS
17.28 SYNBIO TECHNOLOGIES
17.28.1 COMPANY SNAPSHOT
17.28.2 PRODUCT PORTFOLIO
17.28.3 RECENT DEVELOPMENTS
17.29 TRENZYME GMBH
17.29.1 COMPANY SNAPSHOT
17.29.2 PRODUCT PORTFOLIO
17.29.3 RECENT DEVELOPMENTS
17.3 TWIST BIOSCIENCE
17.30.1 COMPANY SNAPSHOT
17.30.2 REVENUE ANALYSIS
17.30.3 PRODUCT PORTFOLIO
17.30.4 RECENT DEVELOPMENTS
18 QUESTIONNAIRE
19 RELATED REPORTS
표 목록
TABLE 1 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET, BY COMPONENT, 2020-2029 (USD MILLION)
TABLE 2 MIDDLE EAST & AFRICA SOFTWARE & SERVICES IN GENE SYNTHESIS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 3 MIDDLE EAST & AFRICA CONSUMABLES IN GENE SYNTHESIS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 4 MIDDLE EAST & AFRICA CONSUMABLES IN GENE SYNTHESIS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 5 MIDDLE EAST & AFRICA SYNTHESIZER IN GENE SYNTHESIS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 6 MIDDLE EAST & AFRICA SYNTHESIZER IN GENE SYNTHESIS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 7 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET, BY GENE TYPE, 2020-2029 (USD MILLION)
TABLE 8 MIDDLE EAST & AFRICA STANDARD GENE IN GENE SYNTHESIS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 9 MIDDLE EAST & AFRICA COMPLEX GENE IN GENE SYNTHESIS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 10 MIDDLE EAST & AFRICA EXPRESS GENE IN GENE SYNTHESIS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 11 MIDDLE EAST & AFRICA OTHERS IN GENE SYNTHESIS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 12 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)
TABLE 13 MIDDLE EAST & AFRICA CUSTOM GENE SYNTHESIS IN GENE SYNTHESIS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 14 MIDDLE EAST & AFRICA CUSTOM GENE SYNTHESIS IN GENE SYNTHESIS MARKET, BY GENE TYPE, 2020-2029 (USD MILLION)
TABLE 15 MIDDLE EAST & AFRICA GENE LIBRARY SYNTHESIS IN GENE SYNTHESIS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 16 MIDDLE EAST & AFRICA GENE LIBRARY SYNTHESIS IN GENE SYNTHESIS MARKET, BY GENE TYPE, 2020-2029 (USD MILLION)
TABLE 17 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 18 MIDDLE EAST & AFRICA SYNTHETIC BIOLOGY IN GENE SYNTHESIS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 19 MIDDLE EAST & AFRICA SYNTHETIC BIOLOGY IN GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)
TABLE 20 MIDDLE EAST & AFRICA GENETIC ENGINEERING IN GENE SYNTHESIS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 21 MIDDLE EAST & AFRICA GENETIC ENGINEERING IN GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)
TABLE 22 MIDDLE EAST & AFRICA THERAPEUTIC ANTIBODIES IN GENE SYNTHESIS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 23 MIDDLE EAST & AFRICA THERAPEUTIC ANTIBODIES IN GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)
TABLE 24 MIDDLE EAST & AFRICA VACCINE DESIGN IN GENE SYNTHESIS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 25 MIDDLE EAST & AFRICA VACCINE DESIGN IN GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)
TABLE 26 MIDDLE EAST & AFRICA OTHERS IN GENE SYNTHESIS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 27 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET, BY METHOD, 2020-2029 (USD MILLION)
TABLE 28 MIDDLE EAST & AFRICA PCR-BASED ENZYME SYNTHESIS IN GENE SYNTHESIS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 29 MIDDLE EAST & AFRICA CHIP-BASED DNA SYNTHESIS IN GENE SYNTHESIS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 30 MIDDLE EAST & AFRICA SOLID BASED SYNTHESIS IN GENE SYNTHESIS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 31 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 32 MIDDLE EAST & AFRICA ACADEMIC & RESEARCH INSTITUTES IN GENE SYNTHESIS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 33 MIDDLE EAST & AFRICA BIOTECH & PHARMACEUTICAL COMPANIES IN GENE SYNTHESIS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 34 MIDDLE EAST & AFRICA DIAGNOSTIC LABORATORIES IN GENE SYNTHESIS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 35 MIDDLE EAST & AFRICA OTHERS IN GENE SYNTHESIS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 36 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 37 MIDDLE EAST & AFRICA DIRECT TENDER IN GENE SYNTHESIS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 38 MIDDLE EAST & AFRICA ONLINE DISTRIBUTION IN GENE SYNTHESIS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 39 MIDDLE EAST & AFRICA THIRD PARTY DISTRIBUTORS IN GENE SYNTHESIS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 40 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET, BY COUNTRY, 2020-2029 (USD MILLION)
TABLE 41 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET, BY COMPONENT, 2020-2029 (USD MILLION)
TABLE 42 MIDDLE EAST & AFRICA CONSUMABLES IN GENE SYNTHESIS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 43 MIDDLE EAST & AFRICA SYNTHESIZER IN GENE SYNTHESIS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 44 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET, BY GENE TYPE, 2020-2029 (USD MILLION)
TABLE 45 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)
TABLE 46 MIDDLE EAST & AFRICA CUSTOM GENE SYNTHESIS IN GENE SYNTHESIS MARKET, BY GENE TYPE, 2020-2029 (USD MILLION)
TABLE 47 MIDDLE EAST & AFRICA GENE LIBRARY SYNTHESIS IN GENE SYNTHESIS MARKET, BY GENE TYPE, 2020-2029 (USD MILLION)
TABLE 48 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 49 MIDDLE EAST & AFRICA SYNTHETIC BIOLOGY IN GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)
TABLE 50 MIDDLE EAST & AFRICA GENETIC ENGINEERING IN GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)
TABLE 51 MIDDLE EAST & AFRICA THERAPEUTIC ANTIBODIES IN GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)
TABLE 52 MIDDLE EAST & AFRICA VACCINE DESIGN IN GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)
TABLE 53 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET, BY METHOD, 2020-2029 (USD MILLION)
TABLE 54 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 55 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 56 SAUDI ARABIA GENE SYNTHESIS MARKET, BY COMPONENT, 2020-2029 (USD MILLION)
TABLE 57 SAUDI ARABIA CONSUMABLES IN GENE SYNTHESIS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 58 SAUDI ARABIA SYNTHESIZER IN GENE SYNTHESIS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 59 SAUDI ARABIA GENE SYNTHESIS MARKET, BY GENE TYPE, 2020-2029 (USD MILLION)
TABLE 60 SAUDI ARABIA GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)
TABLE 61 SAUDI ARABIA CUSTOM GENE SYNTHESIS IN GENE SYNTHESIS MARKET, BY GENE TYPE, 2020-2029 (USD MILLION)
TABLE 62 SAUDI ARABIA GENE LIBRARY SYNTHESIS IN GENE SYNTHESIS MARKET, BY GENE TYPE, 2020-2029 (USD MILLION)
TABLE 63 SAUDI ARABIA GENE SYNTHESIS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 64 SAUDI ARABIA SYNTHETIC BIOLOGY IN GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)
TABLE 65 SAUDI ARABIA GENETIC ENGINEERING IN GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)
TABLE 66 SAUDI ARABIA THERAPEUTIC ANTIBODIES IN GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)
TABLE 67 SAUDI ARABIA VACCINE DESIGN IN GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)
TABLE 68 SAUDI ARABIA GENE SYNTHESIS MARKET, BY METHOD, 2020-2029 (USD MILLION)
TABLE 69 SAUDI ARABIA GENE SYNTHESIS MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 70 SAUDI ARABIA GENE SYNTHESIS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 71 SOUTH AFRICA GENE SYNTHESIS MARKET, BY COMPONENT, 2020-2029 (USD MILLION)
TABLE 72 SOUTH AFRICA CONSUMABLES IN GENE SYNTHESIS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 73 SOUTH AFRICA SYNTHESIZER IN GENE SYNTHESIS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 74 SOUTH AFRICA GENE SYNTHESIS MARKET, BY GENE TYPE, 2020-2029 (USD MILLION)
TABLE 75 SOUTH AFRICA GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)
TABLE 76 SOUTH AFRICA CUSTOM GENE SYNTHESIS IN GENE SYNTHESIS MARKET, BY GENE TYPE, 2020-2029 (USD MILLION)
TABLE 77 SOUTH AFRICA GENE LIBRARY SYNTHESIS IN GENE SYNTHESIS MARKET, BY GENE TYPE, 2020-2029 (USD MILLION)
TABLE 78 SOUTH AFRICA GENE SYNTHESIS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 79 SOUTH AFRICA SYNTHETIC BIOLOGY IN GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)
TABLE 80 SOUTH AFRICA GENETIC ENGINEERING IN GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)
TABLE 81 SOUTH AFRICA THERAPEUTIC ANTIBODIES IN GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)
TABLE 82 SOUTH AFRICA VACCINE DESIGN IN GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)
TABLE 83 SOUTH AFRICA GENE SYNTHESIS MARKET, BY METHOD, 2020-2029 (USD MILLION)
TABLE 84 SOUTH AFRICA GENE SYNTHESIS MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 85 SOUTH AFRICA GENE SYNTHESIS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 86 U.A.E GENE SYNTHESIS MARKET, BY COMPONENT, 2020-2029 (USD MILLION)
TABLE 87 U.A.E CONSUMABLES IN GENE SYNTHESIS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 88 U.A.E SYNTHESIZER IN GENE SYNTHESIS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 89 U.A.E GENE SYNTHESIS MARKET, BY GENE TYPE, 2020-2029 (USD MILLION)
TABLE 90 U.A.E GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)
TABLE 91 U.A.E CUSTOM GENE SYNTHESIS IN GENE SYNTHESIS MARKET, BY GENE TYPE, 2020-2029 (USD MILLION)
TABLE 92 U.A.E GENE LIBRARY SYNTHESIS IN GENE SYNTHESIS MARKET, BY GENE TYPE, 2020-2029 (USD MILLION)
TABLE 93 U.A.E GENE SYNTHESIS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 94 U.A.E SYNTHETIC BIOLOGY IN GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)
TABLE 95 U.A.E GENETIC ENGINEERING IN GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)
TABLE 96 U.A.E THERAPEUTIC ANTIBODIES IN GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)
TABLE 97 U.A.E VACCINE DESIGN IN GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)
TABLE 98 U.A.E GENE SYNTHESIS MARKET, BY METHOD, 2020-2029 (USD MILLION)
TABLE 99 U.A.E GENE SYNTHESIS MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 100 U.A.E GENE SYNTHESIS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 101 ISRAEL GENE SYNTHESIS MARKET, BY COMPONENT, 2020-2029 (USD MILLION)
TABLE 102 ISRAEL CONSUMABLES IN GENE SYNTHESIS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 103 ISRAEL SYNTHESIZER IN GENE SYNTHESIS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 104 ISRAEL GENE SYNTHESIS MARKET, BY GENE TYPE, 2020-2029 (USD MILLION)
TABLE 105 ISRAEL GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)
TABLE 106 ISRAEL CUSTOM GENE SYNTHESIS IN GENE SYNTHESIS MARKET, BY GENE TYPE, 2020-2029 (USD MILLION)
TABLE 107 ISRAEL GENE LIBRARY SYNTHESIS IN GENE SYNTHESIS MARKET, BY GENE TYPE, 2020-2029 (USD MILLION)
TABLE 108 ISRAEL GENE SYNTHESIS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 109 ISRAEL SYNTHETIC BIOLOGY IN GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)
TABLE 110 ISRAEL GENETIC ENGINEERING IN GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)
TABLE 111 ISRAEL THERAPEUTIC ANTIBODIES IN GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)
TABLE 112 ISRAEL VACCINE DESIGN IN GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)
TABLE 113 ISRAEL GENE SYNTHESIS MARKET, BY METHOD, 2020-2029 (USD MILLION)
TABLE 114 ISRAEL GENE SYNTHESIS MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 115 ISRAEL GENE SYNTHESIS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 116 EGYPT GENE SYNTHESIS MARKET, BY COMPONENT, 2020-2029 (USD MILLION)
TABLE 117 EGYPT CONSUMABLES IN GENE SYNTHESIS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 118 EGYPT SYNTHESIZER IN GENE SYNTHESIS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 119 EGYPT GENE SYNTHESIS MARKET, BY GENE TYPE, 2020-2029 (USD MILLION)
TABLE 120 EGYPT GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)
TABLE 121 EGYPT CUSTOM GENE SYNTHESIS IN GENE SYNTHESIS MARKET, BY GENE TYPE, 2020-2029 (USD MILLION)
TABLE 122 EGYPT GENE LIBRARY SYNTHESIS IN GENE SYNTHESIS MARKET, BY GENE TYPE, 2020-2029 (USD MILLION)
TABLE 123 EGYPT GENE SYNTHESIS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 124 EGYPT SYNTHETIC BIOLOGY IN GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)
TABLE 125 EGYPT GENETIC ENGINEERING IN GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)
TABLE 126 EGYPT THERAPEUTIC ANTIBODIES IN GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)
TABLE 127 EGYPT VACCINE DESIGN IN GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)
TABLE 128 EGYPT GENE SYNTHESIS MARKET, BY METHOD, 2020-2029 (USD MILLION)
TABLE 129 EGYPT GENE SYNTHESIS MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 130 EGYPT GENE SYNTHESIS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 131 REST OF MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET, BY COMPONENT, 2020-2029 (USD MILLION)
그림 목록
FIGURE 1 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET: SEGMENTATION
FIGURE 2 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET: GEOGRAPHIC SCOPE
FIGURE 3 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET: DATA TRIANGULATION
FIGURE 4 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET: SNAPSHOT
FIGURE 5 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET: BOTTOM UP APPROACH
FIGURE 6 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET: TOP DOWN APPROACH
FIGURE 7 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET: INTERVIEWS BY REGION AND DESIGNATION
FIGURE 8 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET: DBMR MARKET POSITION GRID
FIGURE 9 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET: END USER COVERAGE GRID
FIGURE 11 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET: THE CATEGORY VS TIME GRID
FIGURE 12 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET SEGMENTATION
FIGURE 13 GROWING PREVALENCE OF CHRONIC INFECTIOUS DISEASES , EXPANSION OF SYNTHETIC BIOLOGY AND RISING ADOPTION OF GENE THERAPY ARE EXPECTED TO DRIVE THE MARKET FOR MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET IN THE FORECAST PERIOD OF 2022 TO 2029
FIGURE 14 SYNTHESIZER SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET IN 2022 & 2029
FIGURE 15 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET
FIGURE 16 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET: BY COMPONENT, 2021
FIGURE 17 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET: BY COMPONENT, 2022-2029 (USD MILLION)
FIGURE 18 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET: BY COMPONENT, CAGR (2022-2029)
FIGURE 19 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET: BY COMPONENT, LIFELINE CURVE
FIGURE 20 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET: BY GENE TYPE, 2021
FIGURE 21 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET: BY GENE TYPE, 2022-2029 (USD MILLION)
FIGURE 22 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET: BY GENE TYPE, CAGR (2022-2029)
FIGURE 23 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET: BY GENE TYPE, LIFELINE CURVE
FIGURE 24 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET: BY GENE SYNTHESIS TYPE, 2021
FIGURE 25 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET: BY GENE SYNTHESIS TYPE, 2022-2029 (USD MILLION)
FIGURE 26 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET: BY GENE SYNTHESIS TYPE, CAGR (2022-2029)
FIGURE 27 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET: BY GENE SYNTHESIS TYPE, LIFELINE CURVE
FIGURE 28 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET: BY APPLICATION, 2021
FIGURE 29 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET: BY APPLICATION, 2022-2029 (USD MILLION)
FIGURE 30 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET: BY APPLICATION, CAGR (2022-2029)
FIGURE 31 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 32 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET: BY METHOD, 2021
FIGURE 33 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET: BY METHOD, 2022-2029 (USD MILLION)
FIGURE 34 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET: BY METHOD, CAGR (2022-2029)
FIGURE 35 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET: BY METHOD, LIFELINE CURVE
FIGURE 36 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET: BY END USER, 2021
FIGURE 37 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET: BY END USER, 2021-2029 (USD MILLION)
FIGURE 38 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET: BY END USER, CAGR (2022-2029)
FIGURE 39 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET: BY END USER, LIFELINE CURVE
FIGURE 40 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET: BY DISTRIBUTION CHANNEL, 2021
FIGURE 41 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET: BY DISTRIBUTION CHANNEL, 2022-2029 (USD MILLION)
FIGURE 42 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET: BY DISTRIBUTION CHANNEL, CAGR (2022-2029)
FIGURE 43 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 44 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET: SNAPSHOT (2021)
FIGURE 45 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET: BY COUNTRY (2021)
FIGURE 46 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET: BY COUNTRY (2022 & 2029)
FIGURE 47 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET: BY COUNTRY (2021 & 2029)
FIGURE 48 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET: BY COMPONENT (2022-2029)
FIGURE 49 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET: COMPANY SHARE 2021 (%)
연구 방법론
데이터 수집 및 기준 연도 분석은 대규모 샘플 크기의 데이터 수집 모듈을 사용하여 수행됩니다. 이 단계에는 다양한 소스와 전략을 통해 시장 정보 또는 관련 데이터를 얻는 것이 포함됩니다. 여기에는 과거에 수집한 모든 데이터를 미리 검토하고 계획하는 것이 포함됩니다. 또한 다양한 정보 소스에서 발견되는 정보 불일치를 검토하는 것도 포함됩니다. 시장 데이터는 시장 통계 및 일관된 모델을 사용하여 분석하고 추정합니다. 또한 시장 점유율 분석 및 주요 추세 분석은 시장 보고서의 주요 성공 요인입니다. 자세한 내용은 분석가에게 전화를 요청하거나 문의 사항을 드롭하세요.
DBMR 연구팀에서 사용하는 주요 연구 방법론은 데이터 마이닝, 시장에 대한 데이터 변수의 영향 분석 및 주요(산업 전문가) 검증을 포함하는 데이터 삼각 측량입니다. 데이터 모델에는 공급업체 포지셔닝 그리드, 시장 타임라인 분석, 시장 개요 및 가이드, 회사 포지셔닝 그리드, 특허 분석, 가격 분석, 회사 시장 점유율 분석, 측정 기준, 글로벌 대 지역 및 공급업체 점유율 분석이 포함됩니다. 연구 방법론에 대해 자세히 알아보려면 문의를 통해 업계 전문가에게 문의하세요.
사용자 정의 가능
Data Bridge Market Research는 고급 형성 연구 분야의 선두 주자입니다. 저희는 기존 및 신규 고객에게 목표에 맞는 데이터와 분석을 제공하는 데 자부심을 느낍니다. 보고서는 추가 국가에 대한 시장 이해(국가 목록 요청), 임상 시험 결과 데이터, 문헌 검토, 재생 시장 및 제품 기반 분석을 포함하도록 사용자 정의할 수 있습니다. 기술 기반 분석에서 시장 포트폴리오 전략에 이르기까지 타겟 경쟁업체의 시장 분석을 분석할 수 있습니다. 귀하가 원하는 형식과 데이터 스타일로 필요한 만큼 많은 경쟁자를 추가할 수 있습니다. 저희 분석가 팀은 또한 원시 엑셀 파일 피벗 테이블(팩트북)로 데이터를 제공하거나 보고서에서 사용 가능한 데이터 세트에서 프레젠테이션을 만드는 데 도움을 줄 수 있습니다.
